Detailed Information
Cited 0 time in 
Cited 0 time in 
Cited 0 time in
Metadata Downloads
Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter]
Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Lyu, Young Sang | - |
| dc.contributor.author | Ahn, Hongyup | - |
| dc.contributor.author | Hong, Sangmo | - |
| dc.contributor.author | Park, Cheol-Young | - |
| dc.date.accessioned | 2025-01-13T11:30:15Z | - |
| dc.date.available | 2025-01-13T11:30:15Z | - |
| dc.date.issued | 2025 | - |
| dc.identifier.issn | 1177-8881 | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/56699 | - |
| dc.description.abstract | [No abstract available] | - |
| dc.format.extent | 2 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | DOVE MEDICAL PRESS LTD | - |
| dc.title | Potential Cardiovascular Risks Associated with Naltrexone-Bupropion Treatment in Overweight Patients [Response to Letter] | - |
| dc.type | Article | - |
| dc.publisher.location | 뉴질랜드 | - |
| dc.identifier.doi | 10.2147/DDDT.S512114 | - |
| dc.identifier.scopusid | 2-s2.0-85215374525 | - |
| dc.identifier.wosid | 001391351800001 | - |
| dc.identifier.bibliographicCitation | Drug Design, Development and Therapy, v.19, pp 65 - 66 | - |
| dc.citation.title | Drug Design, Development and Therapy | - |
| dc.citation.volume | 19 | - |
| dc.citation.startPage | 65 | - |
| dc.citation.endPage | 66 | - |
| dc.type.docType | Letter | - |
| dc.description.isOpenAccess | Y | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
| dc.relation.journalWebOfScienceCategory | Chemistry, Medicinal | - |
| dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
| dc.subject.keywordPlus | THERAPY | - |
| dc.subject.keywordPlus | WEIGHT | - |
| dc.subject.keywordAuthor | Amfebutamone | - |
| dc.subject.keywordAuthor | Amine Oxidase (flavin Containing) | - |
| dc.subject.keywordAuthor | C Reactive Protein | - |
| dc.subject.keywordAuthor | Insulin | - |
| dc.subject.keywordAuthor | Naltrexone | - |
| dc.subject.keywordAuthor | Amfebutamone Plus Naltrexone | - |
| dc.subject.keywordAuthor | Amfebutamone | - |
| dc.subject.keywordAuthor | Amine Oxidase (flavin Containing) | - |
| dc.subject.keywordAuthor | C Reactive Protein | - |
| dc.subject.keywordAuthor | High Density Lipoprotein Cholesterol | - |
| dc.subject.keywordAuthor | Insulin | - |
| dc.subject.keywordAuthor | Low Density Lipoprotein Cholesterol | - |
| dc.subject.keywordAuthor | Monoamine | - |
| dc.subject.keywordAuthor | Naltrexone | - |
| dc.subject.keywordAuthor | Triacylglycerol | - |
| dc.subject.keywordAuthor | Amfebutamone Plus Naltrexone | - |
| dc.subject.keywordAuthor | Blood Pressure | - |
| dc.subject.keywordAuthor | Cardiovascular Risk | - |
| dc.subject.keywordAuthor | Clinical Trial (topic) | - |
| dc.subject.keywordAuthor | Heart Rate | - |
| dc.subject.keywordAuthor | Human | - |
| dc.subject.keywordAuthor | Letter | - |
| dc.subject.keywordAuthor | Lipid Blood Level | - |
| dc.subject.keywordAuthor | Medical Practice | - |
| dc.subject.keywordAuthor | Mental Disease | - |
| dc.subject.keywordAuthor | Obesity | - |
| dc.subject.keywordAuthor | Phase 3 Clinical Trial (topic) | - |
| dc.subject.keywordAuthor | Quality Of Life | - |
| dc.subject.keywordAuthor | Waist Circumference | - |
| dc.subject.keywordAuthor | Drug Therapy | - |
| dc.subject.keywordAuthor | Note | - |
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Natural Science > Department of Statistics > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Related Researcher
- Ahn, Hong Yup
- College of Natural Science (Department of Statistics)